Mystic, CT, United States of America

Ming Zhu Chen


Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
3 patents (USPTO):

Title: Innovations of Ming Zhu Chen

Introduction

Ming Zhu Chen is an accomplished inventor based in Mystic, CT (US). He has made significant contributions to the field of medicinal chemistry, particularly through his work on pyrazole derivatives. With a total of 3 patents to his name, Chen's innovations are paving the way for advancements in the treatment of various disorders.

Latest Patents

Chen's latest patents focus on chemical compounds, specifically pyrazole derivatives. These inventions relate to their use in medicine, compositions containing them, and processes for their preparation. More particularly, his work involves HbS modulators, which are potentially useful in treating a wide range of disorders, including sickle cell disease (SCD). The detailed formulations and processes outlined in his patents highlight the potential impact of these compounds in the medical field.

Career Highlights

Ming Zhu Chen is currently associated with Pfizer Corporation, where he continues to innovate and contribute to the development of new therapeutic solutions. His expertise in chemical compounds and their applications in medicine has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Chen collaborates with talented professionals in his field, including Ariamala Gopalsamy and Arjun Venkat Narayanan. These collaborations enhance the research and development efforts at Pfizer Corporation, fostering an environment of innovation and discovery.

Conclusion

Ming Zhu Chen's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations are making a significant impact on the treatment of serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…